Advanced Search

    column
    Systemic Therapy Is Quietly Changing the Treatment Pattern of Hepatocellular Carcinoma
    MAI Qi-cong, SHI Feng, CHEN Xiao-ming
    2021, 21(6): 321-324. DOI: 10.12019/j.issn.1671-5144.2021.06.001
    Abstract FullText HTML PDF
    Efficacy Comparison Between Atezolizumab Plus Bevacizumab and Sorafenib in Unresectable Hepatocellular Carcinoma
    HU Xiao-yun, CHEN Jin-zhang, WANG Sen-rui
    2021, 21(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2021.06.002
    Abstract FullText HTML PDF
    Adjuvant Lenvatinib in Combination With TACE for HCC Patients With High Risk of Postoperative Relapse: Updated of LANCE Study
    ZHANG Bi-xiang, ZOU Wei
    2021, 21(6): 329-331. DOI: 10.12019/j.issn.1671-5144.2021.06.003
    Abstract FullText HTML PDF
    Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma
    CHEN Shuang-gang, FAN Wei-jun, YANG Yi-fan
    2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
    Abstract FullText HTML PDF
    Preliminary Efficacy and Safety of Perioperative Treatment of Camrelizumab Combined With Apatinib in Resectable Hepatocellular Carcinoma
    Reviewers: JIN Hao-sheng, CHEN Zhi-hong, SHI Ning, Literature Co-worker: LV Ling
    2021, 21(6): 337-340. DOI: 10.12019/j.issn.1671-5144.2021.06.005
    Abstract FullText HTML PDF
    The Value of CDU and UE Alone and Combined in the Diagnosis of Breast Cancer and Axillary Lymph Nodes
    LI Jing-feng, HAN Li
    2021, 21(6): 341-345. DOI: 10.12019/j.issn.1671-5144.2021.06.006
    Abstract FullText HTML PDF
    Expression and Clinical Significance of Long Non-Coding RNA LINC02163 in Non-Small Cell Lung Cancer
    YU Fei, CHEN Juan, SUN Juan, HOU Wei
    2021, 21(6): 346-350. DOI: 10.12019/j.issn.1671-5144.2021.06.007
    Abstract FullText HTML PDF
    Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Lung Cancer
    ZHU Rui-yun, SUN Zhong-wen, HUANG Chang-yang, HE Guo, ZHONG Yu
    2021, 21(6): 351-357. DOI: 10.12019/j.issn.1671-5144.2021.06.008
    Abstract FullText HTML PDF
    The Expression Level of Urokinase-Type Plasminogen Activator （uPA） Was Correlated With Migration and Invasion of Hepatocellular Carcinoma Cells and Systemic Inflammation
    LU Qin, SONG Ye
    2021, 21(6): 358-363. DOI: 10.12019/j.issn.1671-5144.2021.06.009
    Abstract FullText HTML PDF
    Association of PD-L1 Expression With Survival in Large Cell Neuroendocrine Lung Carcinoma and Literature Review
    HUANG Wei-ye, WANG Qian-yu, HE Jiao, LUO Lu-qiao
    2021, 21(6): 364-371. DOI: 10.12019/j.issn.1671-5144.2021.06.010
    Abstract FullText HTML PDF
    Research Progress of Immune Checkpoint Inhibitors in Virus-Associated Cancer Such as Pulmonary Lymphoepithelioma-Like Carcinoma
    ZHONG Yu-min, ZHANG Xu-chao
    2021, 21(6): 372-378. DOI: 10.12019/j.issn.1671-5144.2021.06.011
    Abstract FullText HTML PDF
    Brain Metastasis and Leptomeningeal Metastasis After Surgery for Non-Small Cell Lung Cancer: A Case Report
    LU Hong-lian, SUN Hao, DONG Song
    2021, 21(6): 379-384. DOI: 10.12019/j.issn.1671-5144.2021.06.012
    Abstract FullText HTML PDF